SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055468
Filing Date
2021-11-09
Accepted
2021-11-09 08:39:16
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-10q_20210930.htm   iXBRL 10-Q 2021900
2 EX-31.1 vtvt-ex311_9.htm EX-31.1 17611
3 EX-31.2 vtvt-ex312_7.htm EX-31.2 17524
4 EX-32.1 vtvt-ex321_6.htm EX-32.1 7245
5 EX-32.2 vtvt-ex322_11.htm EX-32.2 7223
6 GRAPHIC g21svogyxmcu000001.jpg GRAPHIC 59104
  Complete submission text file 0001564590-21-055468.txt   7507621

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20210930.xsd EX-101.SCH 60522
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20210930_cal.xml EX-101.CAL 42016
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20210930_def.xml EX-101.DEF 240898
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20210930_lab.xml EX-101.LAB 422955
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20210930_pre.xml EX-101.PRE 329622
12 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-10q_20210930_htm.xml XML 1248776
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 211390037
SIC: 2834 Pharmaceutical Preparations